Progenesis
Private Company
Funding information not available
Overview
Progenesis is a private, commercial-stage diagnostics company focused on the reproductive genetics market. Founded in 2015 (not 2004 as in initial data), it provides a comprehensive portfolio of PGT services and a proprietary software portal to IVF clinics, physicians, and embryologists. The company is CAP-accredited and CLIA-certified, operating with a services-based business model that generates revenue from genetic testing. Its strategy centers on supporting clinical decision-making, expanding global access, and fostering professional education through its Progenesis Academy and GENES Conference.
Technology Platform
Integrated reproductive genetics service platform combining CAP/CLIA-certified laboratory for Preimplantation Genetic Testing (PGT-A, PGT-M, PGT-SR) with the proprietary Revela® online portal for clinic case management, ordering, and secure reporting.
Opportunities
Risk Factors
Competitive Landscape
Progenesis competes in the crowded reproductive genetics market against large, established players like CooperSurgical (CooperGenomics), Natera, and Igenomix. Competition is based on test accuracy, turnaround time, price, the integration of software tools for clinics, and the quality of customer support and clinical collaboration.